ANIX
ANIX
NASDAQ · Biotechnology

Anixa Biosciences Inc

$2.96
+0.21 (+7.64%)
As of Feb 8, 2:12 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.06M 11.02M 11.79M
Net Income 2.28M 2.12M 2.45M
EPS
Profit Margin 18.9% 19.3% 20.8%
Rev Growth +16.3% -0.5% +13.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 49.37M 44.66M 49.52M
Total Equity 31.56M 33.14M 31.76M
D/E Ratio 1.56 1.35 1.56
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.37M 3.22M 3.75M
Free Cash Flow 1.70M 2.02M 1.47M